Harnessing the global expertise in drug use and drug prevention in physical activity settings: results from the Anabolic Steroid Prevention Survey

References

• ACMD. (2010). Consideration of the anabolic steroids. Advisory Council on the Misuse of Drugs (ACMD). https://www.gov.uk/government/publications/advisory-council-on-the-misuse-of-drugs-consideration-of-the-anabolic-steroids
   Google Scholar
• Ajzen, I. (1991). The theory of planned behavior. Organizational Behavior and Human Deicision Processes, 50, 179–211. https://doi.org/10.4135/9781446249215.n22
   Web of Science ®Google Scholar
• Ajzen, I. (2011). The theory of planned behaviour: Reactions and reflections. Psychology & Health, 26(9), 1113–1127. https://doi.org/10.1080/08870446.2011.613995
   PubMed Web of Science ®Google Scholar
• Andreasson, J., & Johansson, T. (2020). Fitness Doping – Trajectories, gender, bodies and health. Palgrave Macmillan.
   Google Scholar
• Atkins, L., Francis, J., Islam, R., O’Connor, D., Patey, A., Ivers, N., Foy, R., Duncan, E. M., Colquhoun, H., Grimshaw, J. M., Lawton, R., & Michie, S. (2017). A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems. Implementation Science, 12(1), 1–18. https://doi.org/10.1186/s13012-017-0605-9
   PubMedGoogle Scholar
• Backhouse, S., Collins, C., Defoort, Y., McNamee, M., Parkinson, A., & Sauer, M. (2014). Study on Doping Prevention: A map of legal, regulatory and prevention practice provisions in EU 28. European Commission. https://op.europa.eu/da/publication-detail/-/publication/792961dc-8428-488c-872a-8f9eb93174f8/language-el
   Google Scholar
• Baggish, A. L., Weiner, R. B., Kanayama, G., Hudson, J. I., Lu, M. T., Hoffmann, U., & Pope, H. G. (2017). Cardiovascular toxicity of illicit anabolic-androgenic steroid use. Circulation, 135(21), 1991–2002. https://doi.org/10.1161/CIRCULATIONAHA.116.026945
   PubMed Web of Science ®Google Scholar
• Bandura, A. (1986). Social foundations of thought and action: A social cognitive theory. Prentice-Hall.
   Google Scholar
• Barkoukis, V., Lazuras, L., Lucidi, F., & Tsorbatzoudis, H. (2015). Nutritional supplement and doping use in sport: Possible underlying social cognitive processes. Scandinavian Journal of Medicine & Science in Sports, 25(6), e582–e588. https://doi.org/10.1111/sms.12377
   PubMed Web of Science ®Google Scholar
• Bartholomew, L. K., Parcel, G. S., Kok, G., & Gottlieb, N. H. (2006). Planning Health Promotion Programs – An Intervention Mapping Approach. Jossey-Bass.
   Google Scholar
• Bates, G., Begley, E., Tod, D., Jones, L., Leavey, C., & McVeigh, J. (2019). A systematic review investigating the behaviour change strategies in interventions to prevent misuse of anabolic steroids. Journal of Health Psychology, 24(11), 1595–1612. https://doi.org/10.1177/1359105317737607
   PubMed Web of Science ®Google Scholar
• Bates, G., Tod, D., Leavey, C., & McVeigh, J. (2019). An evidence-based socioecological framework to understand men’s use of anabolic androgenic steroids and inform interventions in this area. Drugs: Education, Prevention and Policy, 26(6), 484–492. https://doi.org/10.1080/09687637.2018.1488947
   Web of Science ®Google Scholar
• Bates, G., & Vinther, A. S. (2021). Applying insights from implementation and improvement science to improve the evidence base on image and performance-enhancing drugs (IPEDs) interventions. Performance Enhancement & Health, 9(2), 100193. https://doi.org/10.1016/j.peh.2021.100193
   Google Scholar
• Begley, E., McVeigh, J., & Hope, V. (2017). Image and Performance Enhancing Drugs: 2016 National Survey Results. Public Health Institute, Liverpool John Moores University. http://www.wales.nhs.uk/sitesplus/documents/888/IPEDreport2017.FINAL.pdf
   Google Scholar
• Bendtsen, P., Mikkelsen, S. S., & Tolstrup, J. S. (2014). Ungdomsprofilen. Danish Institute for Public Health. https://www.sdu.dk/da/sif/rapporter/2015/ungdomsprofilen_2014
   Google Scholar
• Bergsgard, N. A., Tangen, J. O., Barland, B., & Breivik, G. (1996). Doping in Norwegian Gyms – A big problem? International Review for the Sociology of Sport, 31(4), 351–364. https://doi.org/10.1177/101269029603100401
   Google Scholar
• Blank, C., Kopp, M., Niedermeier, M., Schnitzer, M., & Schobersberger, W. (2016). Predictors of doping intentions, susceptibility, and behaviour of elite athletes: A meta-analytic review. SpringerPlus, 5(1), 1186. https://doi.org/10.1186/s40064-016-3000-0
   PubMedGoogle Scholar
• Boateng, G. O., Neilands, T. B., Frongillo, E. A., Melgar-Quiñonez, H. R., & Young, S. L. (2018). Best Practices for Developing and Validating Scales for Health, Social, and Behavioral Research: A Primer. Frontiers in Public Health, 6, 149–118. https://doi.org/10.3389/fpubh.2018.00149
   PubMed Web of Science ®Google Scholar
• Bonnecaze, A. K., O'Connor, T., & Aloi, J. A. (2020). Characteristics and attitudes of men using Anabolic Androgenic Steroids (AAS): A Survey of 2385 Men. American Journal of Men's Health, 14(6), 1557988320966536. https://doi.org/10.1177/1557988320966536
   Web of Science ®Google Scholar
• Cafri, G., Thompson, J. K., Ricciardelli, L., McCabe, M., Smolak, L., & Yesalis, C. (2005). Pursuit of the muscular ideal: Physical and psychological consequences and putative risk factors. Clinical Psychology Review, 25(2), 215–239. https://doi.org/10.1016/j.cpr.2004.09.003
   PubMed Web of Science ®Google Scholar
• Cane, J., O’Connor, D., & Michie, S. (2012). Validation of the theoretical domains framework for use in behaviour change and implementation research. Implementation Science, 7(1), 1–17. https://doi.org/10.1186/1748-5908-7-37
   Web of Science ®Google Scholar
• Christiansen, A. V. (2020). Gym culture, identity, and performance-enhancing drugs: Tracing a typology of steroid use. Routledge.
   Google Scholar
• Christiansen, A. V., Bloodworth, A., Ham, E., Cox, L., Gatterer, K., & Kjaer, R. S. (2020). Forum for anti-doping in recreational sport (fair): Final report – Chapter 3. EuropeActive. https://www.europeactive-euaffairs.eu/projects/FAIR
   Google Scholar
• Christoffersen, T., Andersen, J. T., Dalhoff, K. P., & Horwitz, H. (2019). Anabolic-androgenic steroids and the risk of imprisonment. Drug and Alcohol Dependence, 203, 92–97. https://doi.org/10.1016/j.drugalcdep.2019.04.041
   PubMed Web of Science ®Google Scholar
• Christou, M. A., Christou, P. A., Markozannes, G., Tsatsoulis, A., Mastorakos, G., & Tigas, S. (2017). Effects of anabolic androgenic steroids on the reproductive system of athletes and recreational users: A systematic review and meta-analysis. Sports Medicine, 47(9), 1869–1883. https://doi.org/10.1007/s40279-017-0709-z
   PubMed Web of Science ®Google Scholar
• Cialdini, R. B., & Goldstein, N. J. (2004). Social influence: Compliance and conformity. Annual Review of Psychology, 55, 591–621. https://doi.org/10.1146/annurev.psych.55.090902.142015
   PubMed Web of Science ®Google Scholar
• Codella, R., Glad, B., Luzi, L., & La Torre, A. (2019). An Italian campaign to promote anti-doping culture in high-school students. Frontiers in Psychology, 10, 1–5. https://doi.org/10.3389/fpsyg.2019.00534
   PubMed Web of Science ®Google Scholar
• Council of Europe. (1989). Anti-Doping Convention. https://www.coe.int/en/web/conventions/full-list/-/conventions/treaty/135
   Google Scholar
• de Hon, O., Kuipers, H., & van Bottenburg, M. (2015). Prevalence of doping use in elite sports: A review of numbers and methods. Sports Medicine, 45(1), 57–69. https://doi.org/10.1007/s40279-014-0247-x
   PubMed Web of Science ®Google Scholar
• Dodge, T., & Hoagland, M. F. (2011). The use of anabolic androgenic steroids and polypharmacy: A review of the literature. Drug and Alcohol Dependence, 114(2–3), 100–109. https://doi.org/10.1016/j.drugalcdep.2010.11.011
   PubMed Web of Science ®Google Scholar
• Donovan, R. J., Egger, G., Kapernick, V., & Mendoza, J. (2002). A conceptual framework for achieving performance enhancing drug compliance in sport. Sports Medicine, 32(4), 269–284. https://doi.org/10.2165/00007256-200232040-00005
   PubMed Web of Science ®Google Scholar
• EHFA. (2012). Fitness Against Doping: Final report: Section 2 – Executive Summary. The European Health & Fitness Association (EHFA). https://www.europeactive-euaffairs.eu/projects/FAD
   Google Scholar
• Gebert, A., Lamprecht, M., Wiegand, D., & Stamm, H. (2017). Prävention im Jugendsport: Beurteilung und Umsetzung des Präventionsprogramms „cool and clean “durch die Trainer”. Pravention Und Gesundheitsforderung, 12(2), 125–131. https://doi.org/10.1007/s11553-017-0579-0
   Google Scholar
• Goldberg, L., Bents, R., Bosworth, E., Trevisan, L., & Elliot, D. L. (1991). Anabolic steroid education and adolescents: Do scare tactics work? Pediatrics, 87(3), 283–286.
   PubMed Web of Science ®Google Scholar
• Goldberg, L., Elliot, D., Clarke, G. N., MacKinnon, D. P., Moe, E., Zoref, L., Green, C., Wolf, S. L., Greffrath, E., Miller, D. J., & Lapin, A. (1996). Effects of a multidimensional anabolic steroid prevention intervention: The adolescents training and learning to avoid steroids (ATLAS) program. JAMA, 276(19), 1555–1562. https://doi.org/10.1001/jama.276.19.1555
   PubMed Web of Science ®Google Scholar
• Goldfield, G. S., & Woodside, D. B. (2009). Body image, disordered eating, and anabolic steroids in male bodybuilders: current versus former users. The Physician and Sportsmedicine, 37(1), 111–114. https://doi.org/10.3810/psm.2009.04.1690.
   PubMed Web of Science ®Google Scholar
• Goldman, A. L., Pope, H. G., & Bhasin, S. (2019). The health threat posed by the hidden epidemic of anabolic steroid use and body image disorders among young men. The Journal of Clinical Endocrinology and Metabolism, 104(4), 1069–1074. https://doi.org/10.1210/jc.2018-01706
   PubMed Web of Science ®Google Scholar
• Hauger, L. E., Havnes, I. A., Jørstad, M. L., & Bjørnebekk, A. (2021). Anabolic androgenic steroids, antisocial personality traits, aggression and violence. Drug and Alcohol Dependence, 221, 108604. https://doi.org/10.1016/j.drugalcdep.2021.108604
   PubMed Web of Science ®Google Scholar
• Hilkens, L., Cruyff, M., Woertman, L., Benjamins, J., & Evers, C. (2021). Social Media, Body Image and Resistance Training: Creating the Perfect ‘Me’ with Dietary Supplements, Anabolic Steroids and SARM’s. Sports Medicine- Open, 7(81), 1–13. https://doi.org/10.1186/s40798-021-00371-1.
   PubMedGoogle Scholar
• Hoffman, J. R., Kraemer, W. J., Bhasin, S., Storer, T., Ratamess, N. A., Haff, G. G., Willoughby, D. S., & Rogol, A. D. (2009). Position stand on androgen and human growth hormone use. Journal of Strength and Conditioning Research, 23, 1–59. https://doi.org/10.1519/JSC.0b013e31819df2e6
   PubMed Web of Science ®Google Scholar
• Holm, S., Tolstrup, J., Thylstrup, B., & Hesse, M. (2016). Neutralization and glorification: Cannabis culture-related beliefs predict cannabis use initiation. Drugs: Education, Prevention and Policy, 23(1), 48–53. https://doi.org/10.3109/09687637.2015.1087967
   Web of Science ®Google Scholar
• Hope, V. D., McVeigh, J., Marongiu, A., Evans-Brown, M., Smith, J., Kimergård, A., Croxford, S., Beynon, C. M., Parry, J. V., Bellis, M. A., & Ncube, F. (2013). Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: A cross-sectional study. BMJ Open, 3(9), 1–11. https://doi.org/10.1136/bmjopen-2013-003207
   Web of Science ®Google Scholar
• Hope, V. D., Veigh, J. M. C., Begley, E., Glass, R., Edmundson, C., Heinsbroek, E., Kean, J., Campbell, J., Whitfield, M., Morgan, G., Acreman, D., & Smith, J. (2021). Factors associated with hepatitis C and HIV testing uptake among men who inject image and performance enhancing drugs. Drug and Alcohol Review, 40(4), 198. https://doi.org/10.1111/dar.13198
   Web of Science ®Google Scholar
• Horwitz, H., Andersen, J. T., & Dalhoff, K. P. (2019). Health consequences of androgenic anabolic steroid use. Journal of Internal Medicine, 285(3), 333–340. https://doi.org/10.1111/joim.12850
   PubMed Web of Science ®Google Scholar
• Hurst, P., Kavussanu, M., Boardley, I., & Ring, C. (2019). Sport supplement use predicts doping attitudes and likelihood via sport supplement beliefs. Journal of Sports Sciences, 37(15), 1734–1740. https://doi.org/10.1080/02640414.2019.1589920
   PubMed Web of Science ®Google Scholar
• Hurst, P., Ring, C., & Kavussanu, M. (2020). An evaluation of UK athletics’ clean sport programme in preventing doping in junior elite athletes. Performance Enhancement and Health, 7, 3–4. https://doi.org/10.1016/j.peh.2019.100155
   Google Scholar
• Ip, E. J., Barnett, M. J., Tenerowicz, M. J., & Perry, P. J. (2011). The anabolic 500 survey: Characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training. Pharmacotherapy, (8), 757–766. https://doi.org/10.1592/phco.31.8.757
   Google Scholar
• Janz, N. K., & Becker, M. H. (1984). The health belief model: A decade later. Health Education Quarterly, 11(1), 1–47. https://doi.org/10.1177/109019818401100101
   PubMedGoogle Scholar
• Johannisson, M. R., Warnecke, M., Berget, J., Coumans, B., Wassink, H., Wigstad, C. R., & Petrou, M. (2012). Strategy for Stopping Steroids. Anti Doping Denmark. https://www.antidoping.dk/udgivelser/undersogelser-og-evalueringer/strategy-for-stopping-steroids
   Google Scholar
• Kanayama, G., Pope, H. G., Cohane, G., & Hudson, J. I. (2003). Risk factors for anabolic-androgenic steroid use among weightlifters: a case–control study. Drug and Alcohol Dependence, 71(1), 77–86. https://doi.org/10.1016/S0376-8716(03)00069-3.
   PubMed Web of Science ®Google Scholar
• Kanayama, G., Hudson, J. I., & Pope, H. G. (2008). Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: A looming public health concern? Drug and Alcohol Dependence, 98(1–2), 1–12. https://doi.org/10.1016/j.drugalcdep.2008.05.004
   PubMed Web of Science ®Google Scholar
• Kartakoullis, N. L., Phellas, C., Pouloukas, S., Petrou, M., & Loizou, C. (2008). The use of anabolic steroids and other prohibited substances by Gym enthusiasts in Cyprus. International Review for the Sociology of Sport, 43(3), 271–287. https://doi.org/10.1177/1012690208098545
   Web of Science ®Google Scholar
• Kavussanu, M., Hurst, P., Yukhymenko-Lescroart, M., Galanis, E., King, A., Hatzigeorgiadis, A., & Ring, C. (2020). A moral intervention reduces doping likelihood in British and Greek Athletes: Evidence from a cluster randomized control trial. Journal of Sport & Exercise Psychology, 43(2), 125–139. https://doi.org/10.1123/jsep.2019-0313
   PubMed Web of Science ®Google Scholar
• Klimek, P., & Hildebrandt, T. (2018). Psychosocial correlates of gap time to anabolic-androgenic steroid use. The International Journal of Eating Disorders, 51(6), 535–541. https://doi.org/10.1002/eat.22859.
   PubMed Web of Science ®Google Scholar
• Lazuras, L., Barkoukis, V., Loukovitis, A., Brand, R., Hudson, A., Mallia, L., Michaelides, M., Muzi, M., Petróczi, A., & Zelli, A. (2017). I want it all, and I want it now: Lifetime prevalence and reasons for using and abstaining from controlled performance and appearance enhancing substances (PAES) among young exercisers and amateur athletes in five European countries. Frontiers in Psychology, 8, 717–719. https://doi.org/10.3389/fpsyg.2017.00717
   PubMed Web of Science ®Google Scholar
• Leifman, H., Rehnman, C., Sjöblom, E., & Holgersson, S. (2011). Anabolic androgenic steroids-use and correlates among gym users-an assessment study using questionnaires and observations at gyms in the Stockholm region. International Journal of Environmental Research and Public Health, 8(7), 2656–2674. https://doi.org/10.3390/ijerph8072656
   PubMed Web of Science ®Google Scholar
• Lenehan, P., Bellis, M., & McVeigh, J. (1996). A study of anabolic steroid use in the North West of England. Journal of Performance Enhancing Drugs, 1(2), 57–70.
   Google Scholar
• Lindqvist, A. S., Moberg, T., Ehrnborg, C., Eriksson, B. O., Fahlke, C., & Rosén, T. (2014). Increased mortality rate and suicide in Swedish former elite male athletes in power sports. Scandinavian Journal of Medicine & Science in Sports, 24(6), 1000–1005. https://doi.org/10.1111/sms.12122
   PubMed Web of Science ®Google Scholar
• Litt, D., & Dodge, T. (2008). A longitudinal investigation of the Drive for Muscularity Scale: Predicting use of performance enhancing substances and weightlifting among males. Body Image, 8, 346–351. https://doi.org/10.1016/j.bodyim.2008.04.002
   Google Scholar
• Lucidi, F., Mallia, L., Alivernini, F., Chirico, A., Manganelli, S., Galli, F., Biasi, V., & Zelli, A. (2017). The effectiveness of a new school-based media literacy intervention on adolescents’ doping attitudes and supplements use. Frontiers in Psychology, 8, 749–749. https://doi.org/10.3389/fpsyg.2017.00749
   PubMed Web of Science ®Google Scholar
• Lundholm, L., Frisell, T., Lichtenstein, P., & Långström, N. (2015). Anabolic androgenic steroids and violent offending: Confounding by polysubstance abuse among 10365 general population men. Addiction, 110(1), 100–108. https://doi.org/10.1111/add.12715
   PubMed Web of Science ®Google Scholar
• MacKinnon, D. P., Goldberg, L., Clarke, G. N., Elliot, D. L., Cheong, J. W., Lapin, A., Moe, E. L., & Krull, J. L. (2001). Mediating mechanisms in a program to reduce intentions to use anabolic steroids and improve exercise self-efficacy and dietary behavior. Prevention Science, 2(1), 15–28. https://doi.org/10.1023/A:1010082828000
   PubMedGoogle Scholar
• Marcello, R. J., Danish, S. J., & Stolberg, A. L. (1989). An evaluation of strategies developed to prevent substance abuse among student-athletes. The Sport Psychologist, 3(3), 196–211. https://doi.org/10.1123/tsp.3.3.196
   Google Scholar
• Marriott-Lloyd, P. (2010). International convention against doping in sport. United Nations Educational, Scientific and Cultural Organization (UNESCO).
   Google Scholar
• Medina, J. Á., Marqueta, P. M., Grao-Cruces, A., Blanco, E. O., Lorente, V. M., & Nuviala, A. N. (2019). Effectiveness of a school-based doping prevention programme in Spanish adolescents. Journal of Human Sport and Exercise, 14(4), 813–820. https://doi.org/10.14198/jhse.2019.144.10
   Web of Science ®Google Scholar
• Michie, S., Carey, R. N., Johnston, M., Rothman, A. J., De Bruin, M., Kelly, M. P., & Connell, L. E. (2018). From theory-inspired to theory-based interventions: A protocol for developing and testing a methodology for linking behaviour change techniques to theoretical mechanisms of action. Annals of Behavioral Medicine, 52(6), 501–512. https://doi.org/10.1007/s12160-016-9816-6
   PubMed Web of Science ®Google Scholar
• Michie, S., van Stralen, M. M., & West, R. (2011). The behaviour change wheel: A new method for characterising and designing behaviour change interventions. Implementation Science, 6(1), 42. https://doi.org/10.1186/1748-5908-6-42
   PubMed Web of Science ®Google Scholar
• Ministry of Health and Social Affairs. (2016, April 14). Continuity and long-term thinking in ANDT work. Retrieved September 21, 2021 from https://www.government.se/articles/2016/04/continuity-and-long-term-thinking-in-andt-work/
   Google Scholar
• Molero, Y., Bakshi, A. S., & Gripenberg, J. (2017). Illicit drug use among gym-goers: A cross-sectional study of gym-goers in Sweden. Sports Medicine – Open, 3(1), 8. https://doi.org/10.1186/s40798-017-0098-8
   PubMedGoogle Scholar
• Molero, Y., Gripenberg, J., & Bakshi, A. S. (2016). Effectiveness and implementation of a community-based prevention programme targeting anabolic androgenic steroid use in gyms: Study protocol of a quasiexperimental control group study. BMC Sports Science, Medicine and Rehabilitation, 8(1), 1–8. https://doi.org/10.1186/s13102-016-0062-9
   PubMedGoogle Scholar
• Murofushi, Y., Kawata, Y., Kamimura, A., Hirosawa, M., & Shibata, N. (2018). Impact of anti-doping education and doping control experience on anti-doping knowledge in Japanese university athletes: A cross-sectional study. Substance Abuse: Treatment, Prevention, and Policy, 13(1), 1–15. https://doi.org/10.1186/s13011-018-0178-x
   PubMedGoogle Scholar
• Nadler, J. T., Weston, R., & Voyles, E. C. (2015). Stuck in the middle: The use and interpretation of mid-points in items on questionnaires. Journal of General Psychology, 142(2), 71–89. https://doi.org/10.1080/00221309.2014.994590
   PubMed Web of Science ®Google Scholar
• Nicholls, A. R., Cope, E., Bailey, R., Koenen, K., Dumon, D., Theodorou, N. C., Chanal, B., Saint Laurent, D., Müller, D., Andrés, M. P., Kristensen, A. H., Thompson, M. A., Baumann, W., & Laurent, J.-F. (2017). Children’s first experience of taking anabolic-androgenic steroids can occur before their 10th birthday: A systematic review identifying 9 factors that predicted doping among young people. Frontiers in Psychology, 8, 1015. https://doi.org/10.3389/fpsyg.2017.01015
   PubMed Web of Science ®Google Scholar
• Nicholls, A. R., Morley, D., Thompson, M. A., Huang, C., Abt, G., Rothwell, M., Cope, E., & Ntoumanis, N. (2020). The effects of the iPlayClean education programme on doping attitudes and susceptibility to use banned substances among high-level adolescent athletes from the UK: A cluster-randomised controlled trial. The International Journal on Drug Policy, 82, 102820. https://doi.org/10.1016/j.drugpo.2020.102820
   PubMed Web of Science ®Google Scholar
• Ntoumanis, N., Ng, J. Y. Y., Barkoukis, V., & Backhouse, S. (2014). Personal and psychosocial predictors of doping use in physical activity settings: A meta-analysis. Sports Medicine, 44(11), 1603–1624. https://doi.org/10.1007/s40279-014-0240-4
   PubMed Web of Science ®Google Scholar
• Ntoumanis, N., Quested, E., Patterson, L., Kaffe, S., Backhouse, S. H., Pavlidis, G., Whitaker, L., Barkoukis, V., Smith, B. J., Staff, H. R., & Gucciardi, D. F. (2021). An intervention to optimise coach-created motivational climates and reduce athlete willingness to dope (CoachMADE): a three-country cluster randomised controlled trial. British Journal of Sports Medicine, 55(4), 213–219. https://doi.org/10.1136/bjsports-2019-101963
   PubMed Web of Science ®Google Scholar
• Nutt, D. J., King, L. A., & Phillips, L. D. (2010). Drug harms in the UK: A multicriteria decision analysis. The Lancet, 376, 1558–1565. https://doi.org/10.1016/S0140-6736(10)61462-6
   PubMed Web of Science ®Google Scholar
• Parkinson, A. B., & Evans, N. A. (2006). Anabolic androgenic steroids: A survey of 500 users. Medicine and Science in Sports and Exercise, 38(4), 644–651. https://doi.org/10.1249/01.mss.0000210194.56834.5d
   PubMed Web of Science ®Google Scholar
• Pärssinen, M., Kujala, U., Vartiainen, E., Sarna, S., & Seppälä, T. (2000). Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. International Journal of Sports Medicine, 21(3), 225–227. https://doi.org/10.1055/s-2000-304
   PubMed Web of Science ®Google Scholar
• Pedersen, I. K. (2010). Doping and the perfect body expert: Social and cultural indicators of performance-enhancing drug use in Danish gyms. Sport in Society, 13(3), 503–516. https://doi.org/10.1080/17430431003588184
   Google Scholar
• Pope, H. G., Kanayama, G., Athey, A., Ryan, E., Hudson, J. I., & Baggish, A. (2014). The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates. The American Journal on Addictions, 23(4), 371–377. https://doi.org/10.1111/j.1521-0391.2013.12118.x.
   PubMed Web of Science ®Google Scholar
• Pope, H. G., Kanayama, G., & Hudson, J. I. (2012). Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: A cross-sectional cohort study. Biological Psychiatry, 71(3), 254–261. https://doi.org/10.1016/j.biopsych.2011.06.024
   PubMed Web of Science ®Google Scholar
• Rasmussen, J. J., Schou, M., Madsen, P. L., Selmer, C., Johansen, M. L., Ulriksen, P. S., Dreyer, T. S., Kümler, T., Plesner, L., Faber, J., Gustafsson, F., & Kistorp, C. (2018). Cardiac systolic dysfunction in past illicit users of anabolic androgenic steroids. American Heart Journal, 203, 49–56. https://doi.org/10.1016/j.ahj.2018.06.010
   PubMed Web of Science ®Google Scholar
• Rasmussen, J. J., Selmer, C., Østergren, P. B., Pedersen, K. B., Schou, M., Gustafsson, F., Faber, J., Juul, A., & Kistorp, C. (2016). Former abusers of anabolic androgenic steroids exhibit decreased testosterone levels and hypogonadal symptoms years after cessation: A case-control study. PLoS One, 11(8), 1–16. https://doi.org/10.1371/journal.pone.0161208
   Web of Science ®Google Scholar
• Rehm, J., Taylor, B., & Room, R. (2006). Global burden of disease from alcohol, illicit drugs and tobacco. Drug and Alcohol Review, 25(6), 503–513. https://doi.org/10.1080/09595230600944453
   PubMed Web of Science ®Google Scholar
• Sagoe, D., Andreassen, C. S., & Pallesen, S. (2014). The aetiology and trajectory of anabolic-androgenic steroid use initiation: A systematic review and synthesis of qualitative research. Substance Abuse: Treatment, Prevention, and Policy, 9(1), 1–14. https://doi.org/10.1186/1747-597X-9-27
   PubMedGoogle Scholar
• Sagoe, D., Holden, G., Rise, E. N. K., Torgersen, T., Paulsen, G., Krosshaug, T., Lauritzenc, F., & Pallesen, S. (2016). Doping prevention through anti-doping education and practical strength training: The Hercules program. Performance Enhancement and Health, 5(1), 24–30. https://doi.org/10.1016/j.peh.2016.01.001
   Google Scholar
• Sagoe, D., McVeigh, J., Bjørnebekk, A., Essilfie, M. S., Andreassen, C. S., & Pallesen, S. (2015). Polypharmacy among anabolic-androgenic steroid users: A descriptive metasynthesis. Substance Abuse: Treatment, Prevention, and Policy, 10(1), 5. https://doi.org/10.1186/s13011-015-0006-5
   PubMedGoogle Scholar
• Sagoe, D., Molde, H., Andreassen, C. S., Torsheim, T., & Pallesen, S. (2014). The global epidemiology of anabolic-androgenic steroid use: A meta-analysis and meta-regression analysis. Annals of Epidemiology, 24(5), 383–398. https://doi.org/10.1016/j.annepidem.2014.01.009
   PubMed Web of Science ®Google Scholar
• Solheim, S. A., Nordsborg, N. B., Ritz, C., Berget, J., Kristensen, A. H., & Mørkeberg, J. (2017). Use of nutritional supplements by Danish elite athletes and fitness customers. Scandinavian Journal of Medicine & Science in Sports, 27(8), 801–808. https://doi.org/10.1111/sms.12704
   PubMed Web of Science ®Google Scholar
• Stewart, B., & Smith, A. C. T. (2008). Drug use in sport. Journal of Sport & Social Issues, 32(3), 278–298. https://doi.org/10.4324/9780429041181-17
   Web of Science ®Google Scholar
• Stubbe, J. H., Chorus, A. M. J., Frank, L. E., de Hon, O., & van der Heijden, P. G. M. (2014). Prevalence of use of performance enhancing drugs by fitness centre members. Drug Testing and Analysis, 6(5), 434–438. https://doi.org/10.1002/dta.1525
   PubMed Web of Science ®Google Scholar
• Tavares, A. S. R., Serpa, S., Horta, L., & Rosado, A. (2019). Psychosocial factors and performance enhancing substances in gym users: A systematic review. Revista de Psicologia Del Deporte, 28(1), 131–142.
   Web of Science ®Google Scholar
• Thiblin, I., Garmo, H., Garle, M., Holmberg, L., Byberg, L., Michaëlsson, K., & Gedeborg, R. (2015). Anabolic steroids and cardiovascular risk: A national population-based cohort study. Drug and Alcohol Dependence, 152, 87–92. https://doi.org/10.1016/j.drugalcdep.2015.04.013
   PubMed Web of Science ®Google Scholar
• UK Anti-Doping. (2019). Image and Performance Enhancing Drugs – UKAD’s status report on IPEDs in the UK. UK Anti-Doping. https://www.ukad.org.uk/news/ukad-warns-against-iped-use-among-gen-z-males-looking-get-better-body-2020
   Google Scholar
• Van Den Berg, P., Neumark-Sztainer, D., Cafri, G., & Wall, M. (2007). Steroid use among adolescents: Longitudinal findings from project EAT. Pediatrics, 119(3), 476–486. https://doi.org/10.1542/peds.2006-2529
   PubMed Web of Science ®Google Scholar
• Vogels, T., Brugman, E., Coumans, B., Danz, M. J., Hirasing, R. A., & Van Kernebeek, E. (1996). Correlates of the use of performance-enhancing drugs among young patrons of gymnasiums in the Netherlands. Drugs: Education, Prevention and Policy, 3(1), 39–48. https://doi.org/10.3109/09687639609019309
   Web of Science ®Google Scholar
• WADA. (2020). 2019 Annual Report. World Anti-Doping Agency. https://www.wada-ama.org/en/resources/finance/annual-report
   Google Scholar
• Wicki, M., Kuntsche, S., Stucki, S., Marmet, S., & Annaheim, B. (2018). Outcome evaluation of ‘Cool and Clean’, a sports-based substance use prevention programme for young people in Switzerland. Health Education Journal, 77(2), 226–240. https://doi.org/10.1177/0017896917745105
   Web of Science ®Google Scholar
• Wiefferink, C. H., Detmar, S. B., Coumans, B., Vogels, T., & Paulussen, T. G. W. (2008). Social psychological determinants of the use of performance-enhancing drugs by gym users. Health Education Research, 23(1), 70–80. https://doi.org/10.1093/her/cym004
   PubMed Web of Science ®Google Scholar
• Wright, S., Grogan, S., & Hunter, G. (2000). Motivations for anabolic steroid use among bodybuilders. Journal of Health Psychology, 5(4), 566–571. https://doi.org/10.1177/135910530000500413
   PubMedGoogle Scholar
• Yager, Z., McLean, S. A., & Li, X. (2019). Body image outcomes in a replication of the ATLAS Program in Australia. Psychology of Men and Masculinity, 20(3), 418–428. https://doi.org/10.1037/men0000173
   Web of Science ®Google Scholar
• Yager, Z., & O’Dea, J. A. (2014). Relationships between body image, nutritional supplement use, and attitudes towards doping in sport among adolescent boys: Implications for prevention programs. Journal of the International Society of Sports Nutrition, 11(1), 13–18. https://doi.org/10.1186/1550-2783-11-13
   PubMed Web of Science ®Google Scholar